Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 1880
  • 1881
  • 1882
  • …
  • ›
  • »

2026-08-11

Ceragon Networks Non-GAAP EPS of $0.02 beats by $0.02, revenue of $93.9M beats by $7.45M

2026-08-11

eToro Group Ltd. Non-GAAP EPS of $0.68 beats by $0.07, revenue of $229M beats by $4.28M

2026-08-11

Autolus Therapeutics GAAP EPS of -$0.15 beats by $0.04, revenue of $45.69M beats by $5.54M

2026-08-11

Legend Biotech Non-GAAP EPS of $0.16 misses by $0.12, revenue of $387.5M beats by $35.75M

2026-08-11

Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates

2026-08-11

Vestis Reports Third Quarter 2026 Results and Increases Full Year 2026 Outlook

2026-08-11

DPC Holdings Reports Strong Second Quarter 2026 Results

2026-08-11

Airo Mechanical Adds Legrande′s Enterprises to Its Growing Business

2026-08-11

SelectQuote to Release Fiscal Fourth Quarter and Full Year 2026 Earnings on August 25

2026-08-11

The Middleby Corporation Reports Second Quarter Results

2026-08-11

IHS Holding Limited Reports Second Quarter 2026 Financial Results

2026-08-11

EQS-News: Vaderis Therapeutics Announces Oversubscribed $152 Million Series B Financing and Initiation of the Global Phase 3 HEROIC Study of Engasertib for Hereditary Hemorrhagic Telangiectasia

  • «
  • ‹
  • …
  • 1880
  • 1881
  • 1882
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 31/Aug/2026 14:20:19
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies